VENU Strangle Strategy

VENU (Venu Holding Corporation), in the Consumer Cyclical sector, (Restaurants industry), listed on AMEX.

Venu Holding Corporation, an entertainment and hospitality company, designs, develops, owns, and operates up-scale music venues, outdoor amphitheaters, and full-service restaurants and bars in the United States. It owns and operates indoor music venues under the Bourbon Brothers Presents name; outdoor music amphitheaters under The Sunset Amphitheater name; restaurants under the Bourbon Brothers Smokehouse & Tavern, Notes Eatery, Roth's Seafood & Chophouse, and Notes Hospitality Collection names; and bars under the Brohan's name. The company also hosts events; and rents event space. Venu Holding Corporation was formerly known as Notes Live, Inc. and changed its name to Venu Holding Corporation in September 2024. The company was incorporated in 2017 and is based in Colorado Springs, Colorado.

VENU (Venu Holding Corporation) trades in the Consumer Cyclical sector, specifically Restaurants, with a market capitalization of approximately $153.2M, a beta of 3.16 versus the broader market, a 52-week range of 3.06-18.17, average daily share volume of 322K, a public-listing history dating back to 2024, approximately 50 full-time employees. These structural characteristics shape how VENU stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 3.16 indicates VENU has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a strangle on VENU?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current VENU snapshot

As of May 15, 2026, spot at $3.76, ATM IV 72.50%, IV rank 24.78%, expected move 20.79%. The strangle on VENU below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this strangle structure on VENU specifically: VENU IV at 72.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a VENU strangle, with a market-implied 1-standard-deviation move of approximately 20.79% (roughly $0.78 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated VENU expiries trade a higher absolute premium for lower per-day decay. Position sizing on VENU should anchor to the underlying notional of $3.76 per share and to the trader's directional view on VENU stock.

VENU strangle setup

The VENU strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With VENU near $3.76, the first option leg uses a $3.95 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed VENU chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 VENU shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$3.95N/A
Buy 1Put$3.57N/A

VENU strangle risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

VENU strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on VENU. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use strangle on VENU

Strangles on VENU are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the VENU chain.

VENU thesis for this strangle

The market-implied 1-standard-deviation range for VENU extends from approximately $2.98 on the downside to $4.54 on the upside. A VENU long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current VENU IV rank near 24.78% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on VENU at 72.50%. As a Consumer Cyclical name, VENU options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to VENU-specific events.

VENU strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. VENU positions also carry Consumer Cyclical sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move VENU alongside the broader basket even when VENU-specific fundamentals are unchanged. Always rebuild the position from current VENU chain quotes before placing a trade.

Frequently asked questions

What is a strangle on VENU?
A strangle on VENU is the strangle strategy applied to VENU (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With VENU stock trading near $3.76, the strikes shown on this page are snapped to the nearest listed VENU chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are VENU strangle max profit and max loss calculated?
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the VENU strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 72.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a VENU strangle?
The breakeven for the VENU strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current VENU market-implied 1-standard-deviation expected move is approximately 20.79%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on VENU?
Strangles on VENU are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the VENU chain.
How does current VENU implied volatility affect this strangle?
VENU ATM IV is at 72.50% with IV rank near 24.78%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related VENU analysis